GI & Endoscopy

Tobira Therapeutics announced results from a 12-week interim analysis of the Phase 2a ORION study.

EndoChoice appointed William Enquist as chairman of the board of directors.

A study published in the Journal of Pediatric Gastroenterology and Nutrition found newborns are likely being over treated the majority of the time with interventions, including surgery, for gastroesophageal reflux disease.

Anthony J. DiMarino Jr., MD, is a gastroenterologist and chief of the division of gastroenterology and hepatology at Thomas Jefferson University in Philadelphia. He is also director of TJU's Digestive Disease Institute and is a William Rorer Professor of Medicine.

Here are six gastroenterologists who recently made headlines.

Michael Phalen, acting executive vice president and president-MedSurg of Boston Scientific, recently sold 35,000 shares of the firm, according to a Franklin Independent report.

CMS' recently released proposed rule implements certain provisions of the Medicare Access and CHIP Reauthorization Act, according to an AGA report.

Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology.

In a study published in Clinical Gastroenterology and Hepatology, researchers did not observe increased prevalence of microscopic colitis among irritable bowel syndrome patients versus other patients with diarrhea undergoing colonoscopy.

Manu R. Sood, MD, is a pediatric gastroenterologist and medical director of gastroenterology at Children's Hospital of Wisconsin in Milwaukee.